These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9094480)

  • 1. First report of sweating associated with topical beta-blocker therapy.
    Schmutz JL; Barbaud A; Reichert S; Vasse JP; Trechot P
    Dermatology; 1997; 194(2):197-8. PubMed ID: 9094480
    [No Abstract]   [Full Text] [Related]  

  • 2. [Case from general practice. Bradycardic atrial flutter].
    Osterwalder P; Garzoli G; Greminger P
    Praxis (Bern 1994); 1998 Aug; 87(33):1034-6. PubMed ID: 9747135
    [No Abstract]   [Full Text] [Related]  

  • 3. Allergic contact dermatitis from carteolol and timolol in eyedrops.
    Quiralte J; Florido F; de San Pedro BS
    Contact Dermatitis; 2000 Apr; 42(4):245. PubMed ID: 10750865
    [No Abstract]   [Full Text] [Related]  

  • 4. Conjunctival vs sublingual administration of carteolol 2% eye drops. Ocular hypotensive effects and some systemic parameter changes.
    Camerino L; Gastaldi C; Brogliatti B; Boles Carenini B
    Acta Ophthalmol Scand Suppl; 1997; (224):52-3. PubMed ID: 9589738
    [No Abstract]   [Full Text] [Related]  

  • 5. Peyronie's disease following long-term use of topical timolol.
    Ross JJ; Rahman I; Walters RF
    Eye (Lond); 2006 Aug; 20(8):974-6. PubMed ID: 16151480
    [No Abstract]   [Full Text] [Related]  

  • 6. The possible treatment of migraine with carteolol hydrochloride.
    Shapiro MK; Gorn R
    Headache; 1999 Feb; 39(2):138-9. PubMed ID: 18567128
    [No Abstract]   [Full Text] [Related]  

  • 7. Beta-blocker eye drops.
    Nurs Times; 2006 May 30-Jun 5; 102(22):29. PubMed ID: 16764382
    [No Abstract]   [Full Text] [Related]  

  • 8. Topical beta blockers and atrioventricular block in the elderly.
    Ruiz-Ruiz FJ; Perez-Calvo JI; Sanjuan-Cuartero R
    J Postgrad Med; 2002; 48(4):327-8. PubMed ID: 12571398
    [No Abstract]   [Full Text] [Related]  

  • 9. New topical beta-blockers for glaucoma.
    Drug Ther Bull; 1987 Aug; 25(16):63-4. PubMed ID: 2887414
    [No Abstract]   [Full Text] [Related]  

  • 10. Nightmares with topical beta-blocker.
    Negi A; Thoung D; Dabbous F
    Eye (Lond); 2000 Oct; 14 Pt 5():813-4. PubMed ID: 11116726
    [No Abstract]   [Full Text] [Related]  

  • 11. [Locally applied cardioselective beta blocker and histamine provocation in patients with obstructive airway disease].
    Bleckmann H; Dorow P
    Fortschr Ophthalmol; 1987; 84(4):346-9. PubMed ID: 2889654
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of topical carteolol on retinal arterial blood flow in primary open-angle glaucoma patients.
    Kawai M; Nagaoka T; Takahashi A; Sato E; Yoshida A
    Jpn J Ophthalmol; 2012 Sep; 56(5):458-63. PubMed ID: 22695833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung-function and glaucoma treatment--a cause for concern?
    Collum LM
    Ir Med J; 1995; 88(1):16. PubMed ID: 7737834
    [No Abstract]   [Full Text] [Related]  

  • 14. Prepared association of metipranolol 0.1% + pilocarpine 2% and of timolol 0.5% + pilocarpine 2%. Comparison of clinical efficacy and topical tolerability in the treatment of patients affected by POAG tonometrically uncontrolled with beta-blocker alone (two-centre study).
    Boles Carenini B; Brogliatti B; Dorigo MT; Vadalà G; Protti R; Bellone A
    Acta Ophthalmol Scand Suppl; 1997; (224):54-5. PubMed ID: 9589740
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of once-daily levobunolol on intraocular pressure in normal-tension glaucoma.
    Inoue K; Ezure T; Wakakura M; Inoue J; Tomita G
    Jpn J Ophthalmol; 2005; 49(1):58-9. PubMed ID: 15692777
    [No Abstract]   [Full Text] [Related]  

  • 16. [Efficacy and safety of timoptic depot in hypotensive therapy of glaucoma].
    Erichev VP; Iakubova LV
    Vestn Oftalmol; 1998; 114(1):8-9. PubMed ID: 9584629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Difficulties in the interpretation of patch test reactions to ophthalmic beta-blockers.
    Carrière M; Giordano-Labadie F; Schwarze HP; Loche F; Bazex J
    Contact Dermatitis; 1998 Dec; 39(6):319-20. PubMed ID: 9874031
    [No Abstract]   [Full Text] [Related]  

  • 18. Allergic contact dermatitis due to the beta-blocker befunolol in eyedrops, with cross-sensitivity to carteolol.
    Nino M; Suppa F; Ayala F; Balato N
    Contact Dermatitis; 2001 Jun; 44(6):369. PubMed ID: 11380552
    [No Abstract]   [Full Text] [Related]  

  • 19. Lichen planus associated with topical beta-blocker therapy.
    Beckman KA; Chanes L; Kaufman SR
    Am J Ophthalmol; 1995 Oct; 120(4):530-1. PubMed ID: 7573315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of diclofenac ophthalmic solution on the intraocular pressure-lowering effect of topical 0.5% timolol and 0.005% latanoprost in primary open-angle glaucoma patients.
    Costagliola C; Parmeggiani F; Antinozzi PP; Caccavale A; Cotticelli L; Sebastiani A
    Exp Eye Res; 2005 Nov; 81(5):610-5. PubMed ID: 15949795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.